[Federal Register Volume 86, Number 237 (Tuesday, December 14, 2021)]
[Notices]
[Pages 71067-71068]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-26956]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[Docket No. CDC-2021-0132]


Advisory Committee on Immunization Practices (ACIP); Meeting

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting and request for comment.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the 
Centers for Disease Control and Prevention (CDC) announces the 
following meeting of the Advisory Committee on Immunization Practices 
(ACIP). This meeting is open to the public. Time will be available for 
public comment. The meeting will be webcast live via the World Wide 
Web.

DATES: The meeting will be held on January 12, 2022, from 10:00 a.m. to 
2:30 p.m., EST (times subject to change). The public may submit written 
comments from December 14, 2021 through January 12, 2022.

ADDRESSES: You may submit comments identified by Docket No. CDC-2021-
0132 by any of the following methods:
     Federal eRulemaking Portal: https://www.regulations.gov. 
Follow the instructions for submitting comments.
     Mail: Centers for Disease Control and Prevention, 1600 
Clifton Road NE, MS H24-8, Atlanta, Georgia 30329-4027, Attn: ACIP 
Meeting.
    Instructions: All submissions received must include the Agency name 
and Docket Number. All relevant comments received in conformance with 
the https://www.regulations.gov suitability policy will be posted 
without change to https://www.regulations.gov, including any personal 
information provided. For access to the docket to read background 
documents or comments received, go to https://www.regulations.gov.
    Written public comments submitted up to 72 hours prior to the ACIP 
meeting will be provided to ACIP members before the meeting.

FOR FURTHER INFORMATION CONTACT: Stephanie Thomas, ACIP Committee 
Management Specialist, National Center for Immunization and Respiratory 
Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road 
NE, MS-H24-8, Atlanta, Georgia 30329-4027; Telephone: (404) 639-8367; 
Email: [email protected].

SUPPLEMENTARY INFORMATION: Purpose: The committee is charged with 
advising the Director, CDC, on the use of immunizing agents. In 
addition, under 42
    U.S.C. 1396s, the committee is mandated to establish and 
periodically review and, as appropriate, revise the list of vaccines 
for administration to vaccine-eligible children through the Vaccines 
for Children program, along with schedules regarding dosing interval, 
dosage, and contraindications to administration of vaccines. Further, 
under provisions of the Affordable Care Act, section 2713 of the Public 
Health Service Act, immunization recommendations of the ACIP that have 
been approved by the CDC Director and appear on CDC immunization 
schedules must be covered by applicable health plans.
    Matters To Be Considered: The agenda will include discussions on 
cholera vaccine, tick-borne encephalitis vaccine, influenza vaccines, 
hepatitis vaccines and respiratory syncytial virus (RSV) vaccine. No 
recommendation votes are scheduled. No Vaccines for Children (VFC) 
votes are scheduled. Agenda items are subject to change as priorities 
dictate. For more information on the meeting agenda visit https://www.cdc.gov/vaccines/acip/meetings/meetings-info.html.

Public Participation

    Interested persons or organizations are invited to participate by 
submitting written views, recommendations, and data. Please note that 
comments received, including attachments and other supporting 
materials, are part of the public record and are subject to public 
disclosure. Comments will be posted on https://www.regulations.gov. 
Therefore, do not include any information in your comment or supporting 
materials that you consider confidential or inappropriate for public 
disclosure. If you include your name,

[[Page 71068]]

contact information, or other information that identifies you in the 
body of your comments, that information will be on public display. CDC 
will review all submissions and may choose to redact, or withhold, 
submissions containing private or proprietary information such as 
Social Security numbers, medical information, inappropriate language, 
or duplicate/near duplicate examples of a mass-mail campaign. CDC will 
carefully consider all comments submitted into the docket.
    Written Public Comment: The docket will be opened to receive 
written comments on December 14, 2021. Written comments must be 
received on or before January 12, 2022.
    Oral Public Comment: This meeting will include time for members of 
the public to make an oral comment. Oral public comment will occur 
before any scheduled votes including all votes relevant to the ACIP's 
Affordable Care Act and Vaccines for Children Program roles. Priority 
will be given to individuals who submit a request to make an oral 
public comment before the meeting according to the procedures below.
    Procedure for Oral Public Comment: All persons interested in making 
an oral public comment at the January 12, 2022 ACIP meeting must submit 
a request at http://www.cdc.gov/vaccines/acip/meetings/ no later than 
11:59 p.m., EST, January 7, 2022, according to the instructions 
provided.
    If the number of persons requesting to speak is greater than can be 
reasonably accommodated during the scheduled time, CDC will conduct a 
lottery to determine the speakers for the scheduled public comment 
session. CDC staff will notify individuals regarding their request to 
speak by email by January 10, 2022. To accommodate the significant 
interest in participation in the oral public comment session of ACIP 
meetings, each speaker will be limited to 3 minutes, and each speaker 
may only speak once per meeting.
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2021-26956 Filed 12-13-21; 8:45 am]
BILLING CODE 4163-18-P